Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis

  • Rahimi-Esboei, Bahman (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Zarei, Mohammad (Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences) ;
  • Mohebali, Mehdi (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Valian, Hossein Keshavarz (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Shojaee, Saeedeh (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Mahmoudzadeh, Raziyeh (Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences) ;
  • Salabati, Mirataollah (Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences)
  • Received : 2017.10.16
  • Accepted : 2018.02.20
  • Published : 2018.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

This prospective study was aimed to detect acute and chronic ocular toxoplasmosis by comparison of anti-Toxoplasma gondii IgM and IgG antibody levels and IgG avidity test. One hundred and seventeen patients with ocular toxoplasmosis (OT) who referred to the Farabi Eye Hospital, Tehran, Iran were included in this study. Of the patients, 77 cases were positive for anti-T. gondii IgG, and 8 cases were positive for anti-T. gondii IgM. IgG avidity test revealed 11, 4, and 102 cases were low, intermediate, and high, respectively, and 6.8% and 9.4% of cases were positive for IgM and IgG avidity tests, respectively (P=0.632). Agreement (Kappa value) between paired tests IgG-IgM, IgG-IgG avidity, and IgM-IgG avidity was 0.080, 0.099, and 0.721, respectively (P<0.05). This study showed that conventional serologic tests (IgM and IgG levels) and IgG avidity correlate well each other and can be used to differentiate recent infections from old OT. It seems that reactivated old infections rather than recently acquired infections are majority of Iranian OT patients.

Keywords

References

  1. Novais EA, Commodaro AG, Santos F, Muccioli C, Maia A, Nascimento A, Moeller CTA, Rizzo LV, Grigg ME, Belfort R Jr. Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood. Br J Ophthalmol 2014; 98: 937-940. https://doi.org/10.1136/bjophthalmol-2013-304184
  2. Ali-Heydari S, Keshavarz H, Shojaee S, Mohebali M. Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting. Parasite 2013; 20: 18. https://doi.org/10.1051/parasite/2013017
  3. Laboudi M, Sadak A. Serodiagnosis of Toxoplasmosis: the effect of measurement of IgG avidity in pregnant women in Rabat in Morocco. Acta Trop 2017; 172: 139-142. https://doi.org/10.1016/j.actatropica.2017.04.008
  4. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8: 634-640. https://doi.org/10.1046/j.1469-0691.2002.00485.x
  5. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002; 185 (Suppl): 73-82. https://doi.org/10.1086/338827
  6. Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg 2014; 90: 794-799. https://doi.org/10.4269/ajtmh.13-0722
  7. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2008; 2: e277. https://doi.org/10.1371/journal.pntd.0000277
  8. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 973-988.
  9. Petersen E, KijlstrabA, Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 2012; 20: 68-75. https://doi.org/10.3109/09273948.2012.661115
  10. Ronday MJ, Stilma JS, Barbe RF, McElroy WJ, Luyendijk L, Kolk AH, Bakker M, Kijlstra A, Rothova A. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol 1996; 80: 956-961. https://doi.org/10.1136/bjo.80.11.956
  11. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R Jr, Vitor RW, Silveira C, Sibley LD. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 2006; 12: 942-949. https://doi.org/10.3201/eid1206.060025
  12. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier M, Silveira S, Camargo ME, Nussenblatt RB, Kaslow RA, Belfort R. An Unusually High Prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992; 114: 136-144. https://doi.org/10.1016/S0002-9394(14)73976-5
  13. Vallochi AL1, Muccioli C, Martins MC, Silveira C, Belfort R Jr, Rizzo LV. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 2005; 139: 350-351. https://doi.org/10.1016/j.ajo.2004.07.040
  14. Silveira C1, Belfort R Jr, Muccioli C, Abreu MT, Martins MC, Victora C, Nussenblatt RB, Holland GN. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001; 131: 351-354. https://doi.org/10.1016/S0002-9394(00)00830-8
  15. Arantes TE, Silveira C, Holland GN, Muccioli C, Yu F, Jones JL, Goldhardt R, Lewis KG, Belfort R Jr. Ocular involvement following postnatally acquired Toxoplasma gondii infection in southern Brazil: a 28-year experience. Am J Ophthalmol 2015; 159: 1002-1012. https://doi.org/10.1016/j.ajo.2015.02.015
  16. Contopoulos-Ioannidis DG, Maldonado Y, Montoya JG. Acute Toxoplasma gondii infection among family members in the United States. Emerg Infect Dis 2013; 19: 1981-1984. https://doi.org/10.3201/eid1912.121892
  17. Grigg ME, Dubey JP, Nussenblatt RB. Ocular toxoplasmosis: lessons from Brazil. Am J Ophthalmol 2015; 159: 999-1001. https://doi.org/10.1016/j.ajo.2015.04.005
  18. Farhadi A, Haniloo A, Fazaeli A, Moradian S, Farhadi M. PCRbased diagnosis of toxoplasma parasite in ocular infections having clinical indications of toxoplasmosis. Iran J Parasitol 2017; 12: 56-62.
  19. Jones JL, Bonetti V, Holland GN, Press C, Sanislo SR, Khurana RN, Montoya JG. Ocular toxoplasmosis in the United States: recent and remote infections. Clin Infect Dis 2015; 60: 271-273. https://doi.org/10.1093/cid/ciu793
  20. Maenz M, Schluter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res 2014; 39: 77-106. https://doi.org/10.1016/j.preteyeres.2013.12.005
  21. Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 1999; 128: 407-412. https://doi.org/10.1016/S0002-9394(99)00266-4
  22. Suresh S, Nor-Masniwati S, Nor-Idahriani MN, Wan-Hazabbah WH, Zeehaida M, Zunaina E. Serological IgG avidity test for ocular toxoplasmosis. 2012; 6: 147-150.
  23. Dodds EM. Toxoplasmosis ocular. Arch Soc Esp Oftalmol 2003; 78: 531-541.
  24. Silveira C, Vallochi AL, Rodrigues da Silva U, Muccioli C, Holland GN, Nussenblatt RB, Belfort R, Rizzo LV. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 2011; 95: 396-400. https://doi.org/10.1136/bjo.2008.148205
  25. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 2007; 77: 405-410.
  26. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 1999; 6: 514-518.
  27. Rahbari AH, Keshavarz H, Shojaee S, Mohebali M, Rezaeian M. IgG avidity ELISA test for diagnosis of acute toxoplasmosis in humans. Korean J Parasitol 2012; 50: 99-102. https://doi.org/10.3347/kjp.2012.50.2.99
  28. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 2004; 48: 386-391. https://doi.org/10.1007/s10384-003-0069-0

Cited by

  1. Evaluation of RE and B1 Genes as Targets for Detection of Toxoplasma gondii by Nested PCR in Blood Samples of Patients with Ocular Toxoplasmosis vol.64, pp.2, 2019, https://doi.org/10.2478/s11686-019-00056-6
  2. Genotyping and phylogenic study of Acanthamoeba isolates from human keratitis and swimming pool water samples in Iran vol.11, pp.None, 2018, https://doi.org/10.1016/j.parepi.2020.e00164
  3. Diagnostic Dilemma and Therapeutic Challenges in Managing an Atypical Presentation of an Ocular Toxoplasmosis Patient With Myasthenia Gravis: Literature Review vol.30, pp.1, 2022, https://doi.org/10.1097/ipc.0000000000001083
  4. Ocular toxoplasmosis, an overview focusing on clinical aspects vol.225, pp.None, 2018, https://doi.org/10.1016/j.actatropica.2021.106180